← Evidence map

ArticleFrontiers in neuroscience2026

Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology.

George R Uhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41987927